Headaches & Chronic Migraines
This session examines the evolving pathophysiology and therapeutic landscape of severe headache disorders and chronic migraines. Topics include Calcitonin Gene-Related Peptide pathway inhibitors, neuromodulation devices, trigeminal nerve sensitization, and medication overuse headaches. Leading pain management specialists at Stroke 2027 will discuss personalized preventative strategies, acute abortive therapies, and the management of cluster headaches. Attendees will acquire evidence-based methodologies to accurately differentiate headache phenotypes, allowing them to deliver targeted, life-altering therapies that enhance patient productivity.